Apollon Wealth Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Apollon Wealth Management's LLY Position: Q3 2026 in Review
Apollon Wealth Management increased its Eli Lilly (LLY) stake by 5.8% in Q3 2026, buying an estimated $4.62M and bringing the position to 71,756 shares worth $83M. The position accounts for 0.95% of the portfolio, ranked #18.
Apollon Wealth Management first reported a position in LLY in Q2 2020 and has held it in 24 quarters since. 1,633 funds tracked by Wall St. Rank hold LLY as of Q3 2026.
- Apollon Wealth Management held 71,756 shares of Eli Lilly worth $83M as of Q3 2026.
- Apollon Wealth Management bought 3,914 Eli Lilly shares in Q3 2026, an estimated $4.62M.
- Eli Lilly made up 0.95% of Apollon Wealth Management's portfolio in Q3 2026, its #18 holding.
- Apollon Wealth Management first reported a position in Eli Lilly in Q2 2020 and has held it in 24 quarters since.
- 1,633 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.
Based on Apollon Wealth Management's 13F filing for Q3 2026, filed 23 Oct 2026.